EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 41 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,265,988 | $12,939,000 | 1.30% |
| Camber Capital Management LP | 1,847,500 | $10,549,000 | 0.72% |
| Cormorant Asset Management, LP | 896,600 | $5,120,000 | 0.68% |
| SOUTHPORT MANAGEMENT, L.L.C. | 50,000 | $286,000 | 0.37% |
| Broadfin Capital, LLC | 775,000 | $4,425,000 | 0.24% |
| BAILARD, INC. | 246,431 | $1,407,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,223,922 | $12,699,000 | 0.06% |
| Lombard Odier Asset Management (USA) Corp | 126,807 | $724,000 | 0.05% |
| ARDSLEY ADVISORY PARTNERS LP | 25,000 | $143,000 | 0.02% |
| Spark Investment Management LLC | 17,900 | $102,000 | 0.01% |